Oppenheimer lowered the firm’s price target on ESAB (ESAB) to $142 from $144 and keeps an Outperform rating on the shares. The firm notes shares dropped a confounding 17.2% after ESAB reported Q2 adjusted EPS of $1.36 vs. its/consensus $1.33/1.36 and raised 2025 guidance ranges. Although the market clearly expected more from the print, Oppenheimer believes tariff-related Americas headwinds are transient and is encouraged by ESAB’s continued HGM outgrowth, stepped-up innovation, and flexibility for strategic/accretive capital deployment going forward. Given ESAB’s strong foundation for flywheel value creation and Wednesday’s sizable pullback, the firm sees current valuation as notably supportive.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ESAB: